Psychosocial Study on Breast Cancer Risk Assessment

This study has been completed.
Sponsor:
Information provided by:
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00234715
First received: October 5, 2005
Last updated: November 13, 2007
Last verified: November 2007
  Purpose

The proposed pilot study is part of the design and development process of a final questionnaire that aims to gain insight on factors that influences acceptance and adoption of breast cancer risk assessment in women. Feedback on the questionnaire will help identify potential issues of clarity, comprehensibility, and reliability; and to identify possible biases that often accompany a designed questionnaire. Information gained from the large-scale study will provide directions for the development of educational strategies in the TIBS research program that could accompany increases in public awareness of risk factors, the availability of risk assessment tools and preventive lifestyle.


Condition
Breast Cancer

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: A Pilot Study: Psychosocial and Socio-Demographic Determinants of Accepting Breast Cancer Risk Assessment

Resource links provided by NLM:


Further study details as provided by University Health Network, Toronto:

Enrollment: 62
Study Start Date: October 2005
Study Completion Date: August 2006
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   25 Years to 74 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Cohort recruited from the University Health Network community.

Criteria

Inclusion Criteria:

  • Are 25 - 74 years of age
  • Are in good health
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00234715

Locations
Canada, Ontario
Ontario Cancer Institute / Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 2M9
Sponsors and Collaborators
University Health Network, Toronto
Investigators
Principal Investigator: Lothar Lilge, PhD Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada M5G 2M9; Department of Biophysics and Bioimaging, University of Toronto, Toronto, Ontario, Canada M5G 2M9
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00234715     History of Changes
Other Study ID Numbers: UHNREB#05-0601-CE
Study First Received: October 5, 2005
Last Updated: November 13, 2007
Health Authority: Canada: Ethics Review Committee

Keywords provided by University Health Network, Toronto:
Breast Cancer
Breast Cancer Risk
Breast Cancer Risk Assessment
Psychosocial
Acceptance

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Neoplasms
Breast Diseases
Skin Diseases

ClinicalTrials.gov processed this record on August 01, 2014